PL344645A1 - Pth2 receptor selective compounds - Google Patents

Pth2 receptor selective compounds

Info

Publication number
PL344645A1
PL344645A1 PL99344645A PL34464599A PL344645A1 PL 344645 A1 PL344645 A1 PL 344645A1 PL 99344645 A PL99344645 A PL 99344645A PL 34464599 A PL34464599 A PL 34464599A PL 344645 A1 PL344645 A1 PL 344645A1
Authority
PL
Poland
Prior art keywords
selective compounds
receptor selective
abnormal
pth2 receptor
pth2
Prior art date
Application number
PL99344645A
Other languages
English (en)
Inventor
Michael Chorev
Zheng Xin Dong
Michael Rosenblatt
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of PL344645A1 publication Critical patent/PL344645A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL99344645A 1998-05-05 1999-05-03 Pth2 receptor selective compounds PL344645A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7295698A 1998-05-05 1998-05-05

Publications (1)

Publication Number Publication Date
PL344645A1 true PL344645A1 (en) 2001-11-19

Family

ID=22110801

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99344645A PL344645A1 (en) 1998-05-05 1999-05-03 Pth2 receptor selective compounds

Country Status (12)

Country Link
US (2) US7531621B1 (enExample)
EP (1) EP1075491B1 (enExample)
JP (1) JP4460157B2 (enExample)
AT (1) ATE392431T1 (enExample)
AU (1) AU3673699A (enExample)
CA (1) CA2327509A1 (enExample)
DE (1) DE69938548T2 (enExample)
ES (1) ES2302374T3 (enExample)
HU (1) HUP0300891A2 (enExample)
NO (1) NO20005556L (enExample)
PL (1) PL344645A1 (enExample)
WO (1) WO1999057139A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK40599A3 (en) 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
UA74130C2 (uk) 1997-05-15 2005-11-15 Чугаі Сейяку Кабусікі Кайся ЗАСТОСУВАННЯ АНТИТІЛА ПРОТИ БІЛКА, СПОРІДНЕНОГО З ПАРАТИРЕОЇДНИМ ГОРМОНОМ (PTHrP), АБО ЙОГО ФУНКЦІОНАЛЬНО АКТИВНОГО ФРАГМЕНТА І/АБО ЙОГО МОДИФІКОВАНОГО ФРАГМЕНТА ДЛЯ ВИРОБНИЦТВА ЛІКАРСЬКОГО ЗАСОБУ ДЛЯ ПРОФІЛАКТИКИ АБО ЛІКУВАННЯ КАХЕКСІЇ
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
CA2373885A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for diseases caused by pth or pthrp
EP1987842A1 (en) 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitor
AU2001292905A1 (en) * 2000-09-19 2002-04-02 Curagen Corporation Method of identifying osteoregenerative agents using differential gene expression
WO2004071396A2 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
CN101522709B (zh) 2006-10-13 2013-03-20 伊莱利利公司 作为pth受体调节剂的聚乙二醇化的pth及其用途
JP5711966B2 (ja) 2007-08-01 2015-05-07 ザ ジェネラル ホスピタル コーポレイション Ｇタンパク質共役受容体および関連組成物を使用するスクリーニング方法
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293158A3 (en) 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US5527772A (en) 1987-10-20 1996-06-18 Holick; Michael F. Regulation of cell proliferation and differentiation using peptides
US4968669A (en) 1988-05-09 1990-11-06 Merck & Co., Inc. Parathyroid hormone antagonists
DE68921665T2 (de) 1988-05-09 1995-09-21 Merck & Co Inc Hemmer vom flüssigen kalziumerhöhenden Faktor.
CA2040264A1 (en) 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
US5087562A (en) 1990-04-25 1992-02-11 Merck & Co., Inc. Humoral hypercalcemic factor antagonists with modification at position 13 . . .
US5093233A (en) 1990-04-25 1992-03-03 Merck & Co., Inc. Antagonists with position 13 modification
US5149779A (en) 1990-07-26 1992-09-22 Merck & Co., Inc. Humoral hypercalcemic factor antagonists
JPH0532696A (ja) 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
CA2098283A1 (en) 1990-12-21 1992-06-22 Richard P. Bozzato Oxidation resistant variants of parathyroid hormone
DE4203040A1 (de) 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5589452A (en) 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5717062A (en) 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
JP3259011B2 (ja) * 1995-08-02 2002-02-18 ミヤチテクノス株式会社 インバータ式抵抗溶接制御方法及び装置
ATE304020T1 (de) 1996-07-31 2005-09-15 Gen Hospital Corp Parathyroidhormon-verwandthe peptidanaloge

Also Published As

Publication number Publication date
US7531621B1 (en) 2009-05-12
ATE392431T1 (de) 2008-05-15
EP1075491B1 (en) 2008-04-16
WO1999057139A3 (en) 2000-02-03
DE69938548T2 (de) 2009-06-18
JP4460157B2 (ja) 2010-05-12
HUP0300891A2 (hu) 2003-07-28
DE69938548D1 (de) 2008-05-29
CA2327509A1 (en) 1999-11-11
WO1999057139A2 (en) 1999-11-11
NO20005556D0 (no) 2000-11-03
US20090226477A1 (en) 2009-09-10
AU3673699A (en) 1999-11-23
NO20005556L (no) 2001-01-03
JP2002513801A (ja) 2002-05-14
EP1075491A2 (en) 2001-02-14
ES2302374T3 (es) 2008-07-01

Similar Documents

Publication Publication Date Title
PL344645A1 (en) Pth2 receptor selective compounds
AU3652102A (en) Compounds and their uses
WO2003105840A3 (en) Sphingosine kinase inhibitors
TNSN04159A1 (fr) Synthese controlee de ziprasidone et compositions en contenant
AU9393601A (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
BG102690A (en) Il-8 receptor antagonists
IL156584A0 (en) Substituted triazole diamine derivatives as kinase inhibitors
CA2338256A1 (en) Bioenhanced formulations comprising eprosartan in oral solid dosage form
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
DE69835225D1 (de) Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
PT1551803E (pt) Derivados azabiciclo como antagonistas do receptor muscarínico
IL164793A0 (en) Methods for increasing the therapeutic response toelectroconvulsive therapy ("ect")
YU2500A (sh) Alatrofloksacin parenteralni preparati
DK1061803T3 (da) Eprosartansammensætninger
PL337361A1 (en) Chalkones of antiproliferative activity
PL328709A1 (en) Mixture of dehydroepiandrosterone and aromatase inhibiting substances and application of such mixture in production of a therapeutic agent for treating relative and absolute hypoadrogenalaemia among male patients
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
MXPA04003544A (es) Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina.
TW200505906A (en) Selective mmp-13 inhibitors
BG103650A (en) Method for the preparation of eprosartan
DK1014789T3 (da) Pressede chloramin-T-tabletter og fremgangsmåde til fremstilling heraf
ZA962176B (en) Use of antioestrogens for controlling male fertility
AU2001262378A1 (en) Method for treating cryptorchidism

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)